Sleep disturbance, distress, and quality of life in ovarian cancer patients during the first year after diagnosis
Open accessAbstract
BACKGROUND: Sleep disturbance is a common clinical complaint of oncology patients and contributes to substantial morbidity. However, because most sleep studies have been cross‐sectional, associations between sleep quality and distress in patients with ovarian cancer over time remain unclear. This prospective longitudinal study examined rates of sleep disturbance; contributions of depression, anxiety, and medication use in sleep disturbance; and associations between sleep quality and quality of life (QOL) during the first year after diagnosis among women with ovarian cancer. METHODS: Women with a pelvic mass completed measures of sleep quality, depression, anxiety, and QOL before surgery. Those diagnosed with primary epithelial ovarian, fallopian tube, or peritoneal cancer repeated surveys at 6 months and 1 year after diagnosis. Mixed modeling was used to examine trajectories of psychosocial measures over time, as well as associations between changes in distress and sleep quality. Relationships between changes in sleep and QOL were also examined. RESULTS: The majority of patients reported disturbed global sleep (Pittsburgh Sleep Quality Index > 5) at all 3 time points. Medications for sleep and pain were associated with worse sleep at all time points. Greater increases in depression were associated with increased disturbances in sleep quality over time (P < .04). Worsening sleep was also associated with declines in QOL over time (P < .001). CONCLUSIONS: Sleep disturbance is common and persistent in women with ovarian cancer, and is linked to depressive symptoms and QOL. Pharmacologic treatment does not appear to adequately address this problem. Results highlight the need for ongoing screening and intervention for sleep disturbance in this population. Cancer 2013;119:3234–3241. © 2013 American Cancer Society.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Physical and psychological symptoms often persist for more than 10 years after cancer treatment.
“These symptoms often persist for more than 10 years’ post-treatment [3–11].”
From Acceptance and commitment therapy in adult cancer survivors: a systematic review and conceptual model (2021) · cites this paper as [6]
The Introduction (page not provided) says sleep disturbance can persist after cancer treatment and cites insomnia symptoms up to 2–5 years after treatment. The Discussion reports persistent sleep disturbance during the first year after ovarian cancer diagnosis. Neither passage supports persistence of physical and psychological symptoms for more than 10 years post-treatment. (LLM, conf=0.86)
Experimental — accuracy not yet measuredOvarian cancer survivors often have long-term symptoms such as anxiety, depression, sleep problems, fatigue, physical symptoms, reduced health-related quality of life, and a poor outlook.
“Ovarian cancer (OC) survivors commonly experience chronic symptoms including anxiety, depression, sleep disturbances, fatigue, physical symptoms, poor health-related quality of life (HRQOL), and a generally poor prognosis.”
From Living Well: Protocol for a web-based program to improve quality of life in rural and urban ovarian cancer survivors (2024) · cites this paper as [3]
The Discussion reports that sleep disturbance commonly persisted through the first year after ovarian cancer diagnosis and was associated with diminished quality of life; the Introduction also describes anxiety as common and notes poor prognosis. The paper links depression to poor sleep, but does not establish that ovarian cancer survivors commonly have chronic fatigue or the unspecified physical symptoms in the claim. Its follow-up extends only to one year, so it does not establish longer-term persistence of the full symptom list. (LLM, conf=0.88)
Experimental — accuracy not yet measuredAdults with cancer commonly have physical and psychological symptoms during and after primary treatment.
“People with cancer experience significant physical and psychological symptoms, during as well as after primary treatment.”
From Acceptance and commitment therapy in adult cancer survivors: a systematic review and conceptual model (2021) · cites this paper as [6]
Experimental — accuracy not yet measuredCancer increases risk for psychological distress, which is linked with poorer quality of life, greater barriers to quality cancer care, and worse morbidity and mortality.
“These coping patterns are important because cancer elevates risk for psychological distress (25) which in turn has been linked with poorer QOL (26–28), greater barriers to quality cancer care (29–33) and worse morbidity and mortality (32–36).”
From Coping in Patients With Incurable Lung and Gastrointestinal Cancers: A Validation Study of the Brief COPE (2017) · cites this paper as [28]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The CES-D Scale: A Self-Report Depression Scale for Research in the General Population
Radloff, L. S. (1977) · Applied Psychological Measurement · doi:10.1177/014662167700100306 · Cited by 53,267 · cited 1× · see citing works
“Higher scores indicate greater depressive symptomatology, with scores 16 consistent with clinical depression.(24) The CES-D is considered a valid and reliable assessment for depressive symptoms in cancer patients.”
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research
Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90047-4 · Cited by 35,234 · cited 1× · see citing works
“The Pittsburgh Sleep Quality Index (PSQI) is a 19-item self-report measure assessing types and frequency of sleep disturbances experienced over the last month.(20) Seven subscale scores are summed to yield a global score; global scores> 5 indicate poor sleep,(20) and scores> 10 are considered to indicate clinically im…”
BackgroundThe functional assessment of cancer therapy scale: development and validation of the general measure
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S. B., Winicour, P., & Brannon, J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.570 · Cited by 6,020 · cited 1× · see citing works
“The FACT provides a total QOL score as well as subscales for physical, functional, social, spiritual, and emotional well-being from 51 items.(30) Statements are rated on a scale from 0 (“not at all”) to 4 (“very much”) and cued to well-being during the previous week.”
BackgroundA review of central 5-HT receptors and their function
Barnes, N. M., & Sharp, T. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00010-6 · Cited by 3,150 · cited 1× · see citing works
“Dysfunctions in the gamma-aminobutyric acid (GABA) system as well as in serotonin receptors have been associated with sleep disturbance and depression.(34,35) Depression has been related to heterogeneous difficulties including sleep maintenance and early morning awakening.”
BackgroundTest–retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia
Backhaus, J., Junghanns, K., Broocks, A., Riemann, D. W., & Hohagen, F. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00330-6 · Cited by 1,762 · cited 1× · see citing works
“is psychometrically sound in patients with cancer(22) and correlates with sleep log data in primary insomnia.(23)”
BackgroundPsychometric evaluation of the pittsburgh sleep quality index
Carpenter, J. S., & Andrykowski, M. A. (1998) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(97)00298-5 · Cited by 1,618 · see citing works
A Shortened Version of the Profile of Mood States
Shacham, S. (1983) · Journal of Personality Assessment · doi:10.1207/s15327752jpa4703_14 · Cited by 1,231 · see citing works
Maier, S. F., & Watkins, L. R. (1998) · Psychological Review · doi:10.1037/0033-295x.105.1.83 · Cited by 1,130 · cited 1× · see citing works
“High levels of circulating proinflammatory cytokines such as IL-6 have in turn been associated with central vegetative symptoms including fatigue, malaise, and sleep alterations, as well as depressive symptoms.(41) Thus, it is possible that tumor-derived inflammation may contribute to both depressive symptoms and slee…”
BackgroundSmith, M. T., & Haythornthwaite, J. A. (2004) · Sleep Medicine Reviews · doi:10.1016/s1087-0792(03)00044-3 · Cited by 914 · cited 1× · see citing works
“Bidirectional relationships may exist between chronic pain and sleep disturbance.(43) Specifically, chronic pain is thought to contribute to poorer sleep, which in turn may increase pain sensitivity.”
BackgroundManber, R., Edinger, J. D., Gress, J. L., Pedro-Salcedo, M. G. S., Kuo, T. F., & Kalista, T. (2008) · Sleep · doi:10.1093/sleep/31.4.489 · Cited by 868 · see citing works
Measurement of depressive symptoms in cancer patients
Hann, D., Winter, K., & Jacobsen, P. (1999) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(99)00004-5 · Cited by 822 · cited 1× · see citing works
“The CES-D is considered a valid and reliable assessment for depressive symptoms in cancer patients.(25,26)”
BackgroundCarlson, L. E., & Garland, S. N. (2005) · International Journal of Behavioral Medicine · doi:10.1207/s15327558ijbm1204_9 · Cited by 556 · cited 1× · see citing works
“For example, behavioral interventions such as cognitive behavioral therapy and mindfulness-based stress reduction have known effectiveness for insomnia(46,47) and have shown positive benefits in oncology patients.(48,49)”
Irwin, M. R., Cole, J. C., & Nicassio, P. M. (2006) · Health Psychology · doi:10.1037/0278-6133.25.1.3 · Cited by 537 · see citing works
Role of GABA in anxiety and depression
Kalueff, A. V., & Nutt, D. (2006) · Depression and Anxiety · doi:10.1002/da.20262 · Cited by 536 · cited 1× · see citing works
“Dysfunctions in the gamma-aminobutyric acid (GABA) system as well as in serotonin receptors have been associated with sleep disturbance and depression.(34,35) Depression has been related to heterogeneous difficulties including sleep maintenance and early morning awakening.”
BackgroundSavard, J., Simard, S., Ivers, H., & Morin, C. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.548 · Cited by 507 · cited 1× · see citing works
“For example, behavioral interventions such as cognitive behavioral therapy and mindfulness-based stress reduction have known effectiveness for insomnia(46,47) and have shown positive benefits in oncology patients.(48,49)”
Frequency of Symptoms of Ovarian Cancer in Women Presenting to Primary Care Clinics
Goff, B. A. (2004) · JAMA · doi:10.1001/jama.291.22.2705 · Cited by 503 · see citing works
Psychometric evaluation of the Pittsburgh Sleep Quality Index in cancer patients
Beck, S. L., Schwartz, A. L., Towsley, G., Dudley, W., & Barsevick, A. (2004) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2003.12.002 · Cited by 464 · see citing works
Chou, C., & Bentler, P. M. (1990) · Multivariate Behavioral Research · doi:10.1207/s15327906mbr2501_13 · Cited by 411 · cited 1× · see citing works
“Covariance structure was evaluated with Wald z-tests of rho covariance parameters and comparison of Schwarz’s Bayesian criterion (BIC) between models with different covariance structures, as suggested by existing literature.(32,33) First-order autoregressive covariance structures were supported for all models by signi…”
MethodEffects of sleep and sleep loss on immunity and cytokines
Irwin, M. R. (2002) · Brain Behavior and Immunity · doi:10.1016/s0889-1591(02)00003-x · Cited by 366 · cited 1× · see citing works
“Alternatively, sleep and cytokines may have a bidirectional relationship whereby alterations in sleep influence cytokine expression, and cytokines in turn have a regulatory influence on sleep.(42) Bidirectional relationships may exist between chronic pain and sleep disturbance.”
BackgroundSleep and Quality of Life in Breast Cancer Patients
Fortner, B. V., Stepanski, E. J., Wang, S. C., Kasprowicz, S., & Durrence, H. H. (2002) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(02)00500-6 · Cited by 329 · see citing works
Sleep Disturbance and Depression Recurrence in Community-Dwelling Older Adults: A Prospective Study
Cho, H. J., Lavretsky, H., Olmstead, R., Levin, M. J., Oxman, M. N., & Irwin, M. R. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07121882 · Cited by 318 · cited 1× · see citing works
“determined, and it is possible that sleep disturbance may lead to depression as well.(45) Because of the minimal numbers of women taking hormone replacement therapy in this sample, influences of hormone replacement on sleep could not be examined.”
BackgroundDepression, Anxiety, and Quality of Life in Patients with Epithelial Ovarian Cancer
Bodurka, D. C., Basen-Engquist, K. M., Carmack, C. L., Fitzgerald, M. A., Wolf, J. K., de Moor, C., & Gershenson, D. M. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5908 · Cited by 312 · see citing works
Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer
Ancoli‐Israel, S., Liu, L., Marler, M., Parker, B. A., Jones, V. E., Sadler, G. R., Dimsdale, J. E., Cohen‐Zion, M., & Fiorentino, L. (2005) · Supportive Care in Cancer · doi:10.1007/s00520-005-0861-0 · Cited by 306 · cited 2× · see citing works
“Disturbed sleep and fatigue have been reported in women with breast cancer even before initiation of treatment.(9) Generally, sleep disturbance in patients with breast or prostate cancer declines over the 6 months following treatment.”
BackgroundResultSpiegel, D. (1996) · The British Journal of Psychiatry · doi:10.1192/s0007125000298486 · Cited by 304 · see citing works
Lindley, C. M., Vasa, S. A., Sawyer, W. T., & Winer, E. P. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1380 · Cited by 296 · cited 1× · see citing works
“3% of women treated for early-stage breast cancer still have symptoms of insomnia for up to 2 to 5 years after treatment completion.(11) Because of poor prognosis and rigorous treatment protocols,(12) patients with ovarian cancer often suffer high distress at the time of diagnosis and during treatment,(13) potentially…”
BackgroundSchroevers, M. J., Sanderman, R., van Sonderen, E., & Ranchor, A. V. (2000) · Quality of Life Research · doi:10.1023/a:1016673003237 · Cited by 249 · see citing works
Redeker, N. S., Lev, E. L., & Ruggiero, J. S. (2000) · Research and theory for nursing practice · doi:10.1891/0889-7182.14.4.275 · Cited by 242 · cited 1× · see citing works
“Disturbed sleep has functional consequences as it has been associated with poorer quality of life (QOL) in women with breast cancer, including impaired ability to perform work and daily tasks,(6) although not all studies have yielded consistent results.(7) A recent study of patients with ovarian cancer within 5 years…”
BackgroundCancer pain, fatigue, distress, and insomnia in cancer patients
Theobald, D. (2004) · Clinical cornerstone · doi:10.1016/s1098-3597(05)80003-1 · Cited by 217 · cited 1× · see citing works
“Although untreated pain may contribute to discomfort and inability to initiate and maintain sleep, analgesic medications may produce daytime side effects that also interfere with nighttime sleep.(44) Although there was not a direct measure of pain in the current study, the present findings support an association betwe…”
ResultAnderson, K. O., Getto, C. J., Mendoza, T. R., Palmer, S. N., Wang, X. S., Reyes‐Gibby, C. C., & Cleeland, C. S. (2003) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(02)00682-6 · Cited by 210 · see citing works
Interleukin-6, Cortisol, and Depressive Symptoms in Ovarian Cancer Patients
Lutgendorf, S. K., Weinrib, A., Penedo, F. J., Russell, D. W., DeGeest, K., Costanzo, E. S., Henderson, P. J., Sephton, S. E., Rohleder, N., Lucci, J. A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.1978 · Cited by 201 · see citing works
Self-citationPalesh, O. G., Collie, K., Batiuchok, D., Tilston, J., Koopman, C., Perlis, M. L., Butler, L. D., Carlson, R., & Spiegel, D. (2007) · Biological Psychology · doi:10.1016/j.biopsycho.2006.11.002 · Cited by 183 · cited 2× · see citing works
“The associations between depressive mood and sleep disturbance are consistent with findings in patients with metastatic breast cancer, where depressive symptoms predict worsening of sleep over time.(16)”
BackgroundResultSocial support, anxiety and depression after chemotherapy for ovarian cancer: A prospective study
Hipkins, J., Whitworth, M. K., Tarrier, N., & Jayson, G. C. (2004) · British Journal of Health Psychology · doi:10.1348/1359107042304542 · Cited by 173 · cited 1× · see citing works
“These data thus extend previous cross-sectional descriptions of sleep problems in ovarian cancer.(18,19) These data highlight risk factors associated with disturbed sleep trajectories and reveal that sustained sleep disruptions have a significant impact on patients’ overall QOL.”
ResultQuality of life and mental health in cervical and endometrial cancer survivors
Bradley, S., Rose, S. L., Lutgendorf, S. K., Costanzo, E. S., & Anderson, B. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.08.023 · Cited by 164 · cited 1× · see citing works
“The Profile of Mood States short-form (POMS-SF) is a 37-item inventory assessing 6 dimensions of mood(27) often used in research with patients who have cancer.(28,29) This study used the anxiety subscale as the indicator of anxiety.”
MethodSelf-citationSerum Evaluation of Interleukin 6 in Ovarian Cancer Patients
Tempfer, C. M., Zeisler, H., Sliutz, G., Haeusler, G., Hanzal, E., & Kainz, C. (1997) · Gynecologic Oncology · doi:10.1006/gyno.1997.4726 · Cited by 133 · see citing works
Lutgendorf, S. K., Mullen-Houser, E., Russell, D. W., DeGeest, K., Jacobson, G., Hart, L. K., Bender, D., Anderson, B., Buekers, T., Goodheart, M. J., et al. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.06.014 · Cited by 133 · cited 1× · see citing works
“The Profile of Mood States short-form (POMS-SF) is a 37-item inventory assessing 6 dimensions of mood(27) often used in research with patients who have cancer.(28,29) This study used the anxiety subscale as the indicator of anxiety.”
MethodSelf-citationSleep/Wake Patterns of Individuals With Advanced Cancer Measured by Ambulatory Polysomnography
Parker, K. P., Bliwise, D. L., Ribeiro, M. H. L., Jain, S. R., Vena, C. I., Kohles-Baker, M. K., Rogatko, A., Xu, Z., & Harris, W. B. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.2135 · Cited by 116 · cited 1× · see citing works
“Rates of sleep disturbance in patients with cancer are higher than in the general population(1) and have been documented by polysomnography.(2) Among patients with heterogeneous advanced cancers, 72% reported sleep disturbance, with common complaints including difficulties with sleep onset and maintenance, not feeling…”
BackgroundCoping and quality of life among women extensively treated for gynecologic cancer
Costanzo, E. S., Lutgendorf, S. K., Rothrock, N. E., & Anderson, B. (2006) · Psycho-Oncology · doi:10.1002/pon.930 · Cited by 114 · see citing works
Self-citationSleep disturbance, cytokines, and fatigue in women with ovarian cancer
Clevenger, L., Schrepf, A., Christensen, D., DeGeest, K., Bender, D., Ahmed, A. I., Goodheart, M. J., Penedo, F. J., Lubaroff, D. M., Sood, A. K., et al. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.04.003 · Cited by 99 · cited 1× · see citing works
“For example, we and others have previously reported elevations in the proinflammatory cytokine interleukin-6 (IL-6)(38,39) and links between poorer sleep quality and elevated IL-6 in patients with ovarian cancer.(40) High levels of circulating proinflammatory cytokines such as IL-6 have in turn been associated with ce…”
BackgroundSelf-citationSleep disturbances in palliative cancer patients attending a pain and symptom control clinic
Sela, R. A., Watanabe, S., & Nekolaichuk, C. (2005) · Palliative & Supportive Care · doi:10.1017/s1478951505050042 · Cited by 84 · cited 1× · see citing works
“Among patients with heterogeneous advanced cancers, 72% reported sleep disturbance, with common complaints including difficulties with sleep onset and maintenance, not feeling rested in the morning, and daytime fatigue.(3) Chemotherapy has been associated with significantly poorer sleep quality(4) and daytime sleepine…”
BackgroundThe effect of sleep disturbance on quality of life in women with ovarian cancer
Sandadi, S., Frasure, H. E., Broderick, M. J., Waggoner, S. E., Miller, J. M., & von Gruenigen, V. E. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.07.028 · Cited by 79 · cited 2× · see citing works
“The proportion of patients with ovarian cancer reporting sleep disturbances at each of the measured time points was similar to rates in other oncology populations.(8,9) At all time Figure 2.”
BackgroundResultThomas, K. S., Bower, J. E., Hoyt, M. A., & Sepah, S. (2009) · Psycho-Oncology · doi:10.1002/pon.1639 · Cited by 78 · cited 1× · see citing works
“Generally, sleep disturbance in patients with breast or prostate cancer declines over the 6 months following treatment.(10) However, at least one study has found”
BackgroundInfluentialComparison of subjective sleep quality in patients with cancer and healthy subjects.
Owen, D. C., Parker, K., & McGuire, D. B. (1999) · PubMed · Cited by 69 · see citing works
Quality of sleep and related factors during chemotherapy in patients with stage I/II breast cancer.
Kuo, H., Chiu, M., Liao, W., & Hwang, S.-L. (2006) · Journal of the Formosan Medical Association = Taiwan yi zhi · doi:10.1016/s0929-6646(09)60110-8 · Cited by 66 · cited 1× · see citing works
“Chemotherapy has been associated with significantly poorer sleep quality(4) and daytime sleepiness.(5) Disturbed sleep has functional consequences as it has been associated with poorer quality of life (QOL) in women with breast cancer, including impaired ability to perform work and daily tasks,(6) although not all stu…”
BackgroundPrevalence and predictors of insomnia in women with invasive ovarian cancer: anxiety a major factor
Price, M. A., Zachariae, R., Butow, P. N., deFazio, A., Chauhan, D., Espie, C. A., Friedlander, M., & Webb, P. M. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.05.030 · Cited by 56 · cited 2× · see citing works
“These data thus extend previous cross-sectional descriptions of sleep problems in ovarian cancer.(18,19) These data highlight risk factors associated with disturbed sleep trajectories and reveal that sustained sleep disruptions have a significant impact on patients’ overall QOL.”
BackgroundResultSleep and depression - theory and practice.
Berk, M. (2009) · PubMed · Cited by 51 · see citing works
Premature Menopause After Cancer Treatment
Lin, E. M., Aikin, J. L., & Good, B. C. (1999) · Cancer Practice · doi:10.1046/j.1523-5394.1999.07306.x · Cited by 24 · cited 2× · see citing works
“Surgical oophorectomy induces an immediate menopause and thus may initiate the onset of classic menopausal symptoms such as nocturnal temperature fluctuations and hot flashes, both of which interfere with sleep.(14) In addition, facing a life-threatening diagnosis at a younger age and/or loss of childbearing status ma…”
Background
Flagged first, then by citations
Research works printed but not linked: 1
- [31]Rubin S Society of Gynecologic Oncologists: Chemotherapy of Gynecologic Cancers 2004 2nd ed. Philadelphia Lippincott Williams and Wilkins
Cited by
Sorted by citations
Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates
Watts, S., Leydon, G., Birch, B. R., Prescott, P., Lai, L. Y. W., Eardley, S., & Lewith, G. T. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-003901 · Cited by 461 · see citing works
Depression and anxiety in ovarian cancer: a systematic review and meta-analysis of prevalence rates
Watts, S., Prescott, P., Mason, J., McLeod, N., & Lewith, G. T. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-007618 · Cited by 211 · see citing works
Depression and Insomnia in Cancer: Prevalence, Risk Factors, and Effects on Cancer Outcomes
Irwin, M. R. (2013) · Current Psychiatry Reports · doi:10.1007/s11920-013-0404-1 · Cited by 165 · see citing works
“Clevenger et al. [52] prospectively examined rates of sleep disturbance; contributions of depression, anxiety, and medication use in sleep disturbance; and associations between sleep quality and quality of life (QOL) during the first year after diagnosis among women with ovarian cancer.”
Prevalence of sleep disturbance in patients with cancer: a systematic review and meta-analysis
Al Maqbali, M., Al Sinani, M., Alsayed, A., & Gleason, A. M. (2022) · Clinical Nursing Research · doi:10.1177/10547738221092146 · Cited by 167 · see citing works
“These results could be explained as this meta-analysis included seven gynecological types of cancer, which six of them (Clevenger et al., 2012, 2013; Li et al., 2017a; Sandadi et al., 2011; Tian et al., 2015; Yu & Nho, 2015) reported patients during anti-cancer treatments, and eight lung types of…”
BackgroundStrollo, S. E., Fallon, E. A., Gapstur, S. M., & Smith, T. G. (2020) · Sleep Medicine · doi:10.1016/j.sleep.2019.10.008 · Cited by 132 · see citing works
Measurements and status of sleep quality in patients with cancers
Chen, D., Zongyi, Y., & Fang, B. (2017) · Supportive Care in Cancer · doi:10.1007/s00520-017-3927-x · Cited by 124 · see citing works
“Sleep disturbance is also one of the most common symptoms and related to depression and quality of life in patients with gynecologic cancer, especially during the treatment period of chemotherapy [5, 105].”
Diurnal cortisol and survival in epithelial ovarian cancer
Schrepf, A., Thaker, P. H., Goodheart, M. J., Bender, D., Slavich, G. M., Dahmoush, L., Penedo, F. J., DeGeest, K., Méndez, L., Lubaroff, D. M., et al. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.01.010 · Cited by 103 · see citing works
Self-citationSleep disturbance, cytokines, and fatigue in women with ovarian cancer
Clevenger, L., Schrepf, A., Christensen, D., DeGeest, K., Bender, D., Ahmed, A. I., Goodheart, M. J., Penedo, F. J., Lubaroff, D. M., Sood, A. K., et al. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.04.003 · Cited by 99 · see citing works
Self-citationMathew, A., Doorenbos, A. Z., Jang, M. K., & Hershberger, P. E. (2021) · Journal of Cancer Survivorship · doi:10.1007/s11764-020-00938-z · Cited by 91 · see citing works
Hagan, T. L., Fishbein, J. N., Nipp, R. D., Jacobs, J. M., Traeger, L., Irwin, K. E., Pirl, W. F., Greer, J. A., Park, E. R., Jackson, V. A., et al. (2017) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2016.06.005 · Cited by 88 · see citing works
Long-term and Short-term Effects of Insomnia in Cancer and Effective Interventions
Davis, M. P., & Goforth, H. W. (2014) · The Cancer Journal · doi:10.1097/ppo.0000000000000071 · Cited by 83 · see citing works
“Premenopausal women may be particularly predisposed to sleep disturbances in the perioperative period.(228) Outside increased pain with poor sleep in the postoperative setting, there are a few studies addressing outcomes to perioperative sleep disorders and long-term implications of perioperative sleep dysfunction on…”
BackgroundSymptom clustering and quality of life in patients with ovarian cancer undergoing chemotherapy
Nho, J., Kim, S. R., & Nam, J.-H. (2017) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2017.07.007 · Cited by 81 · see citing works
George, G. C., Iwuanyanwu, E. C., Anderson, K. O., Yusuf, A., Zinner, R., Piha-Paul, S. A., Tsimberidou, A. M., Naing, A., Fu, S., Jankú, F., et al. (2016) · Cancer · doi:10.1002/cncr.30182 · Cited by 66 · see citing works
Tian, J., Chen, G. L., & Zhang, H. R. (2014) · Supportive Care in Cancer · doi:10.1007/s00520-014-2493-8 · Cited by 64 · see citing works
“In a prospective longitudinal study, by examining contributions of depression and anxiety in sleep disturbance during the first year after diagnosis among ovarian cancer patients, studies have suggested that higher incidence in depression and anxiety are associated with increased disturbances in sleep quality over tim…”
BackgroundEffects of Slow-Stroke Back Massage on Symptom Cluster in Adult Patients With Acute Leukemia
Miladinia, M., Molavynejad, S., Shariati, A., & Malehi, A. S. (2016) · Cancer Nursing · doi:10.1097/ncc.0000000000000353 · Cited by 60 · see citing works
Dickerson, S. S., Connors, L. M., Fayad, A., & Dean, G. E. (2014) · Nature and Science of Sleep · doi:10.2147/nss.s34846 · Cited by 59 · see citing works
Bastos, D. B., Sarafim-Silva, B. A. M., Sundefeld, M. L. M. M., Ribeiro, A., Brandão, J. D. P., Biasoli, É. R., Miyahara, G. I., Casarini, D. E., & Bernabé, D. G. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202515 · Cited by 57 · see citing works
Joly, F., Ahmed-Lecheheb, D., Kalbacher, E., Heutte, N., Clarisse, B., Grellard, J., Gernier, F., Berton-Rigaud, D., Trédan, O., Fabbro, M., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz074 · Cited by 57 · see citing works
Internet-Based Group Intervention for Ovarian Cancer Survivors: Feasibility and Preliminary Results
Kinner, E. M., Armer, J. S., McGregor, B. A., Duffecy, J., Leighton, S., Corden, M. E., Gauthier Mullady, J., Penedo, F. J., & Lutgendorf, S. K. (2018) · JMIR Cancer · doi:10.2196/cancer.8430 · Cited by 51 · see citing works
“During the first year following primary treatment, patients report high levels of anxiety and depressive symptoms, sleep disturbance, fatigue, and treatment side effects (eg, peripheral neuropathy), which impacts their overall quality of life (QOL) [3,5].”
BackgroundInfluentialSelf-citationHoang, H. T. X., Molassiotis, A., Chan, C. W., Nguyen, T. H., & Nguyen, V. L. (2019) · Sleep And Breathing · doi:10.1007/s11325-019-01839-x · Cited by 56 · see citing works
“Insomnia caused cancer patients to be less able to copewith stress and carry onwith their daily activities and had greater difficulty dealing with emotional problems [14, 15], which impaired them physically and emotionally [48, 49].”
BackgroundMathew, A. E., Doorenbos, A. Z., & Vincent, C. (2020) · Advances in Nursing Science · doi:10.1097/ans.0000000000000347 · Cited by 49 · see citing works
A comparison of two psychological interventions for newly-diagnosed gynecological cancer patients
Manne, S. L., Virtue, S. M., Ozga, M., Kashy, D., Heckman, C., Kissane, D., Rosenblum, N., Morgan, M., & Rodriquez, L. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.11.025 · Cited by 45 · see citing works
Lutgendorf, S. K., Shinn, E. H., Carter, J., Leighton, S. L., Baggerly, K., Guindani, M., Fellman, B. M., Matzo, M. L., Slavich, G. M., Goodman, M. T., et al. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.05.008 · Cited by 45 · see citing works
Self-citationCoping and Quality of Life in Turkish Women Living with Ovarian Cancer
Tuncay, T. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.9.4005 · Cited by 44 · see citing works
“…and psychological function that may occur with ovarian cancer, overall evaluation of quality of life is relatively moderate or high (e.g. Guidozzi, 1993; Ersek et al., 1997; Goker et al., 2011; Xia et al., 2011; Clevenger et al., 2013; Price et al., 2013; Srisuttayasathien and Khemapech, 2013).”
BackgroundGonzalez, B. D., Eisel, S. L., Qin, B., Llanos, A. A. M., Savard, J., Hoogland, A. I., Jim, H., Lin, Y., Demissie, K., Hong, C., et al. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-020-05786-2 · Cited by 46 · see citing works
“Another study of women with ovarian cancer found a temporal relationship, such that improvements in sleep quality from diagnosis to 1 year later were associated with improvements in QoL [16].”
BackgroundInfluentialSantoso, A. M. M., Jansen, F., Lissenberg-Witte, B. I., de Jong, R. J. B., Langendijk, J. A., Leemans, C. R., Smit, J. H., Takes, R. P., Terhaard, C. H. J., van Straten, A., et al. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-020-05577-9 · Cited by 43 · see citing works
“Sleep quality before the start of cancer treatment is also known to be associated with HRQoL throughout the cancer trajectory [5, 6]; thus, early detection of poor sleep quality is necessary to initiate prehabilitation strategy to optimize HRQoL during and after HNC treatment [7].”
BackgroundZhou, Y., Irwin, M. L., Ferrucci, L. M., McCorkle, R. C., Ercolano, E. A., Li, F., Stein, K., & Cartmel, B. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.04.006 · Cited by 41 · see citing works
Polysomnographic Study of Sleep in Survivors of Breast Cancer
Reinsel, R. A., Starr, T. D., O’Sullivan, B., Passik, S. D., & Kavey, N. B. (2015) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.5264 · Cited by 39 · see citing works
Kuo, H., Tsao, Y., Tu, H., Dai, Z., & Creedy, D. K. (2018) · Research in Nursing & Health · doi:10.1002/nur.21885 · Cited by 36 · see citing works
Beesley, V. L., Webber, K., Nagle, C. M., DeFazio, A., Obermair, A., Williams, M., Friedlander, M. L., & Webb, P. M. (2020) · Gynecologic Oncology · doi:10.1016/j.ygyno.2020.07.029 · Cited by 36 · see citing works
Palagini, L., Miniati, M., Massa, L., Folesani, F., Marazziti, D., Grassi, L. G., & Riemann, D. W. (2021) · Journal of Sleep Research · doi:10.1111/jsr.13510 · Cited by 35 · see citing works
“Clevenger et al. (2013) 173 women > 18 years with OC recruited pre- surgically and followed- up at 6 months and 1 year after treatment.”
BackgroundInsomnia and its association with quality of life in women with ovarian cancer
Ross, T. L., DeFazio, A., Friedlander, M. L., Grant, P., Nagle, C. M., Williams, M., Webb, P. M., & Beesley, V. L. (2020) · Gynecologic Oncology · doi:10.1016/j.ygyno.2020.06.500 · Cited by 33 · see citing works
Beesley, V. L., Ross, T. L., King, M. T., Campbell, R., Nagle, C. M., Obermair, A., Grant, P., DeFazio, A., Webb, P. M., & Friedlander, M. L. (2021) · Gynecologic Oncology · doi:10.1016/j.ygyno.2021.12.006 · Cited by 33 · see citing works
Peoples, A. R., Garland, S. N., Perlis, M. L., Savard, J., Heckler, C. E., Kamen, C. S., Ryan, J. L., Mustian, K. M., Janelsins, M. C., Peppone, L. J., et al. (2017) · Journal of Cancer Survivorship · doi:10.1007/s11764-017-0597-0 · Cited by 33 · see citing works
Chang, W., & Lin, C. (2017) · Chronobiology International · doi:10.1080/07420528.2017.1293678 · Cited by 32 · see citing works
“Notably, Clevenger et al. (2013) asserted that depressive symptoms are highly correlated with poor sleep quality.”
BackgroundResultCha, K. M., Chung, Y. K., Lim, K. Y., Noh, J. S., Chun, M., Hyun, S. Y., Kang, D. R., Oh, M. J., & Kim, N. H. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.04.020 · Cited by 31 · see citing works
Wu, I. H. C., Tsai, W., McNeill, L. H., & Lu, Q. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-019-05233-x · Cited by 29 · see citing works
“Recent estimates suggest that symptoms of insomnia and sleep disturbance among BCSs can range from 42 to 63% for 1-year and 18-month post-treatment, respectively [3, 6].”
Backgroundde Arruda, F. N., Oonk, M. H. M., Mourits, M. J. E., de Graeff, P., Jalving, M., & de Bock, G. H. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2019.03.249 · Cited by 29 · see citing works
Sleep and gynecological cancer outcomes: opportunities to improve quality of life and survival
Zhao, C., Grubbs, A. E., & Barber, E. L. (2022) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2022-003404 · Cited by 29 · see citing works
Horsbøl, T. A., Kjær, S. K., Johansen, C., Suppli, N. P., Ammitzbøll, G., Frøding, L. P., Lajer, H., & Dalton, S. O. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2019.03.259 · Cited by 29 · see citing works
Distinct sleep disturbance profiles among patients with gynecologic cancer receiving chemotherapy
Pozzar, R. A., Hammer, M. J., Paul, S. M., Cooper, B. A., Kober, K. M., Conley, Y. P., Levine, J. D., & Miaskowski, C. A. (2021) · Gynecologic Oncology · doi:10.1016/j.ygyno.2021.09.002 · Cited by 24 · see citing works
Oral cannabidiol for prevention of acute and transient chemotherapy-induced peripheral neuropathy
Nielsen, S. W., Hasselsteen, S. D., Dominiak, H. S. H., Labudovic, D., Reiter, L., Dalton, S. O., & Herrstedt, J. (2022) · Supportive Care in Cancer · doi:10.1007/s00520-022-07312-y · Cited by 24 · see citing works
Symptom Clusters and Quality of Life According to the Survivorship Stage in Ovarian Cancer Survivors
Kim, M., Kim, K., Lim, C., & Kim, J. (2017) · Western Journal of Nursing Research · doi:10.1177/0193945917701688 · Cited by 23 · see citing works
“…receiving chemotherapy for ovarian cancer (Gil et al., 2007; von Gruenigen et al., 2009), either in the acute survival stage of ovarian cancer (Clevenger et al., 2013; Matulonis et al., 2008; Mirabeau-Beale et al., 2009) or in the permanent survival stage of ovarian cancer (Kornblith et al.,…”
BackgroundSleep disturbance among Chinese breast cancer survivors living in the USA
Gonzalez, B. D., & Lü, Q. (2018) · Supportive Care in Cancer · doi:10.1007/s00520-018-4128-y · Cited by 23 · see citing works
“Previous studies among mostly White female cancer survivors found that 45% reported elevated sleep disturbance [14] and had average PSQI scores of 6.”
ResultSleep disturbance among women with chronic pelvic pain
Çoşar, E., Güngör, A. N. Ç., Gencer, M., Uysal, A., Hacıvelioğlu, S., Özkan, A., & Şen, H. M. (2014) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2014.03.034 · Cited by 22 · see citing works
Sleep quality of endometrial cancer survivors and the effect of treatments
İlhan, T. T., Uçar, M. G., Gül, A., Ilhan, T. S., Yavaş, G., & Çelık, Ç. (2017) · Journal of Turkish Society of Obstetric and Gynecology · doi:10.4274/tjod.59265 · Cited by 22 · see citing works
“Before surgery, patients with ovarian cancer reported a high sleep disorder rate(22).”
BackgroundFox, R. S., Baik, S. H., McGinty, H. L., Garcia, S. F., Reid, K. J., Bovbjerg, K., Fajardo, P., Wu, L. M., Shahabi, S., Ong, J. C., et al. (2020) · International Journal of Behavioral Medicine · doi:10.1007/s12529-020-09861-0 · Cited by 21 · see citing works
“Similarly, longitudinal improvements in depressive symptoms are associated with improvements in global sleep [13], indicating that depression can confer increased risk for poor sleep quality.”
BackgroundSelf-citationAtaseven, B., Frindte, J., Harter, P., Gebers, G., Vogt, C., Traut, A., Breit, E., Bluni, V., Reinisch, M., Heitz, F., et al. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-05216-y · Cited by 21 · see citing works
What Can Social Media Tell Us About Patient Symptoms
Lee, Y. J., Park, A., Roberge, M. C., & Donovan, H. S. (2020) · Cancer Nursing · doi:10.1097/ncc.0000000000000860 · Cited by 17 · see citing works
Patient reported outcomes measures in gynecologic oncology: A primer for clinical use, part I
Sisodia, R. C., Dewdney, S. B., Fader, A. N., Wethington, S. L., Melamed, A., von Gruenigen, V. E., Zivanovic, O., Carter, J., Cohn, D. E., Huh, W. K., et al. (2020) · Gynecologic Oncology · doi:10.1016/j.ygyno.2020.04.696 · Cited by 18 · see citing works
Distinct Sleep Disturbance Profiles in Patients With Gastrointestinal Cancers Receiving Chemotherapy
Lin, Y., Bailey, D. E., Docherty, S. L., Porter, L. S., Cooper, B. A., Paul, S. M., Hammer, M. J., Conley, Y. P., Levine, J. D., & Miaskowski, C. A. (2021) · Cancer Nursing · doi:10.1097/ncc.0000000000000975 · Cited by 19 · see citing works
Trajectories of sleep disturbance in cancer survivors during the first 2 years post-treatment
Chan, J., Ng, D. W. L., Liao, Q., Fielding, R., Soong, I., Chan, K. K. L., Lee, C., Ng, A. W.-Y., Sze, W. K., Chan, W., et al. (2023) · SLEEP · doi:10.1093/sleep/zsad052 · Cited by 19 · see citing works
Circadian, hormonal, and sleep rhythms: effects on cancer progression implications for treatment
Jagielo, A. D., Benedict, C., & Spiegel, D. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1269378 · Cited by 18 · see citing works
Tabaczynski, A., Courneya, K. S., & Trinh, L. (2020) · Cancer Causes & Control · doi:10.1007/s10552-020-01308-x · Cited by 18 · see citing works
Padron, A., McCrae, C. S., Robinson, M. E., Waxenberg, L. B., Antoni, M. H., Berry, R. B., Castagno, J., Schultz, G., Kacel, E. L., Ulfig, C., et al. (2022) · Behavioral Sleep Medicine · doi:10.1080/15402002.2021.1932500 · Cited by 17 · see citing works
“Insomnia is a prevalent cancer outcome associated with mood disorders, low quality of life (QOL), inflammation, immune dysregulations, and mortality (Clevenger et al., 2012, 2013; Peoples et al., 2017).”
BackgroundWu, H.-J., Chuang, C.-M., Chien, C., Wang, T.-J. T., & Liang, S. (2021) · Cancer Nursing · doi:10.1097/ncc.0000000000000986 · Cited by 17 · see citing works
Analysis of preoperative sleep quality and related influencing factors in cancer patients
Wang, Z., Du, W., Jin, S., Zhu, Y., Quan, C., Zhang, X., Feng, Y., Mo, Y., & Wang, J. (2022) · Supportive Care in Cancer · doi:10.1007/s00520-022-07483-8 · Cited by 17 · see citing works
“Sleep disturbances have been shown to be one of the risk factors for poor prognosis in cancer patients [13, 23], especially in hospitalized patients pending surgery.”
BackgroundHyphantis, T. N., Goulia, P., Zerdes, I., Solomou, S., Andreoulakis, E., Carvalho, A. F., & Pavlidis, N. A. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3843-1 · Cited by 17 · see citing works
“Sleep-related problems might lead to greater morbidity and impaired quality of life (QoL) [5], hence identifying and treating them is of paramount importance.”
BackgroundYeh, Y. (2021) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2021.101984 · Cited by 17 · see citing works
Calvo‐Schimmel, A., Paul, S. M., Cooper, B. A., Shin, J., Harris, C., Oppegaard, K. R., Hammer, M. J., Cartwright, F., Conley, Y. P., Kober, K. M., et al. (2022) · Cancer Nursing · doi:10.1097/ncc.0000000000001139 · Cited by 16 · see citing works
Saeki, Y., Sumi, Y., Ozaki, Y., Hosonaga, M., Kenmotsu, Y., Onoe, T., Yamaguchi, K. D., & Matsumoto, Y. (2024) · Cancer Medicine · doi:10.1002/cam4.70365 · Cited by 16 · see citing works
Associations among menopausal symptoms, sleep and fatigue in Taiwanese women with endometrial cancer
Li, C., Tsai, Y., Chang, T., & Chen, L. (2016) · European Journal of Cancer Care · doi:10.1111/ecc.12559 · Cited by 16 · see citing works
Insomnia in Cancer - Associations and Implications
George, M., Elias, A., & Shafiei, M. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.15.6711 · Cited by 15 · see citing works
“These findings have been reported elsewhere (Clevenger et al., 2013; Nishiura et al., 2014).”
Anderson, R. T., Peres, L. C., CAMACHO, F. T., Bandera, E. V., Funkhouser, E. M., Moorman, P. G., Paddock, L. E., Peters, E. S., Abbott, S. E., Alberg, A. J., et al. (2018) · Journal of Women s Health · doi:10.1089/jwh.2018.7025 · Cited by 15 · see citing works
Schrier, E., Xiong, N., Thompson, E., Poort, H., Schumer, S., Liu, J. F., Krasner, C. N., Campos, S. M., Horowitz, N. S., Feltmate, C. M., et al. (2021) · Gynecologic Oncology · doi:10.1016/j.ygyno.2021.02.023 · Cited by 15 · see citing works
Kerner, H., Samuels, N., Moshe, S. B., Sharabi, I. S., & Ben‐Arye, E. (2017) · BMJ Supportive & Palliative Care · doi:10.1136/bmjspcare-2017-001351 · Cited by 14 · see citing works
Psychosocial resources and sleep disturbance before chemotherapy for gynecologic cancer
Evans, B., Phillips, K. M., Gonzalez, B. D., Apte, S. M., Small, B. J., Jacobsen, P. B., & Jim, H. (2016) · Journal of Psychosocial Oncology · doi:10.1080/07347332.2015.1128507 · Cited by 14 · see citing works
“Sleep disturbance in cancer patients co-occurs with other symptoms (Ancoli-Israel et al., 2014; Clevenger et al., 2013; Dean et al., 2013) and may in fact initiate a cascade of symptoms by contributing to fatigue, which in turn contributes to depression (Jim et al., 2011).”
BackgroundChronodisruption and Ambulatory Circadian Monitoring in Cancer Patients: Beyond the Body Clock
Pagán, P., Torrente, M., Campos, M., Provencio, M., Madrid, J. A., Franco, F., Morilla, B. R., Cantos, B., Sousa, P., Martínez-Madrid, M. J., et al. (2022) · Current Oncology Reports · doi:10.1007/s11912-021-01158-z · Cited by 13 · see citing works
Shaunfield, S. L., Jensen, S. E., Fisher, A. P., Webster, K., Shahabi, S., Ganguli, A. X., & Cella, D. F. (2019) · Health and Quality of Life Outcomes · doi:10.1186/s12955-019-1253-3 · Cited by 12 · see citing works
Oswald, L. B., Eisel, S. L., Tometich, D. B., Bryant, C., Hoogland, A. I., Small, B. J., Apte, S. M., Chon, H. S., Shahzad, M. M. K., Gonzalez, B. D., et al. (2022) · Health Psychology · doi:10.1037/hea0001190 · Cited by 11 · see citing works
Schofield, C., Newton, R. U., Galvao, D. A., Cohen, P. A., & Peddle‐McIntyre, C. J. (2017) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000001044 · Cited by 11 · see citing works
Schofield, C., Newton, R. U., Galvao, D. A., Cohen, P. A., & Peddle-McIntyre, C. J. (2017) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000001045 · Cited by 10 · see citing works
David, C., Beijer, S., Mols, F., Oerlemans, S., Husson, O., Weijenberg, M. P., & Ezendam, N. P. M. (2024) · Journal of Cancer Survivorship · doi:10.1007/s11764-024-01641-z · Cited by 9 · see citing works
“Lastly, various psychosocial factors including anxiety, depression, and fatigue have been negatively associated with sleep problems among cancer survivors [8, 9, 13, 14, 21–23].”
Yao, L., Zhang, Z., & Lam, L. T.-M. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1211561 · Cited by 9 · see citing works
Guo, Z., Wang, Y., Liu, W., Huang, H., Tang, X., Wu, Z., Lu, L., Fan, B., Cui, S., & Xu, N. (2024) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2024.103074 · Cited by 8 · see citing works
Cancer patient-family caregiver mutuality: A concept analysis
Joung, H. H., & Jones, R. A. (2025) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2025.102891 · Cited by 8 · see citing works
Kırca, N., Adıbelli, D., Toptaş, T., & Yilmaz, Ş. (2025) · Supportive Care in Cancer · doi:10.1007/s00520-025-09674-5 · Cited by 8 · see citing works
“Insomnia can often be severe enough to require medical treatment [16].”
Price, S. N., Hamann, H. A., Halaby, L., Trejo, J. I., Corella, F., & Weihs, K. L. (2022) · Behavioral Sleep Medicine · doi:10.1080/15402002.2022.2033243 · Cited by 8 · see citing works
“…to identify patients with some degree of insomnia (Buysse et al., 1989), while a higher cutoff of >10 has been suggested to identify possible clinically significant insomnia (Okun et al., 2009) and for evaluating sleep problems in women with cancer (Clevenger et al., 2013; Reinsel et al., 2015).”
BackgroundYu, S.-Y., & Nho, J. (2015) · Asian Oncology Nursing · doi:10.5388/aon.2015.15.4.203 · Cited by 8 · see citing works
Chan, J., Ng, D. W. L., Fielding, R., & Lam, W. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-06344-4 · Cited by 10 · see citing works
Prevalence of Anxiety May Not be Elevated in Thai Ovarian Cancer Patients Following Treatment
Chittrakul, S., Charoenkwan, K., & Wongpakaran, N. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.3.1251 · Cited by 7 · see citing works
“As a consequence, one would expect an increase in prevalence of anxiety in women diagnosed with ovarian cancer (Reid et al., 2011; Clevenger et al., 2013).”
BackgroundGarvin, L. A., Slavich, G. M., Schrepf, A., Davis, L. Z., Thaker, P. H., Goodheart, M. J., Cole, S. W., Sood, A. K., & Lutgendorf, S. K. (2021) · Psycho-Oncology · doi:10.1002/pon.5682 · Cited by 7 · see citing works
Self-citationLiu, D., Shi, G., Yin, C., Liu, Z., & Yang, A. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/1075513 · Cited by 6 · see citing works
“0, FACT-OV4) was used to evaluate the quality of life [13], including social/family status, emotional status, functional status, and physiological status.”
MethodA randomized pilot of eHealth mindful movement and breathing to improve gynecologic surgery outcomes
Sohl, S. J., Tooze, J. A., Levine, B. J., Zeidan, F. Z., Wheeler, A. E., Kelly, M., Shalowitz, D. I., & Danhauer, S. C. (2022) · Journal of Psychosocial Oncology · doi:10.1080/07347332.2022.2101908 · Cited by 6 · see citing works
Zhang, Y., Peng, R. Y., Cheng, N., Wang, R. T., Nan, M. D., Milazzo, S., Pilkington, K., Seely, D., Horneber, M., & Liu, J. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010145.pub2 · Cited by 5 · see citing works
Qiu, T., Zhang, T., Zhang, Y., & Qiu, X. (2025) · The International Journal of Psychiatry in Medicine · doi:10.1177/00912174251350465 · Cited by 5 · see citing works
Gao, Z., Gao, Z., Chen, Z., Ma, J., Zhao, Y., Zhang, L., & Guo, L. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05580-y · Cited by 4 · see citing works
Gu, Z., Wang, J., Yang, C. X., & Wu, H. L. (2024) · Nature and Science of Sleep · doi:10.2147/nss.s457651 · Cited by 4 · see citing works
Predictors of Quality of Life in Young Adults Diagnosed With Cancer
McKie, C., & Laiyemo, A. O. (2020) · Clinical Nursing Research · doi:10.1177/1054773820928197 · Cited by 4 · see citing works
The incidence of postoperative sleep disturbance and its influencing factors in cancer patients
Wang, Z., Zhang, X., Gao, S., Zhang, Y., Liu, D., & Peng, J. M. (2025) · Journal of Anesthesia and Translational Medicine · doi:10.1016/j.jatmed.2025.12.001 · Cited by 3 · see citing works
Sarkar, S., Pal, R., Mahata, S., Sahoo, P. K., Ghosh, S., Chatterjee, P., Vernekar, M., Mandal, S., Bera, T., & Nasare, V. D. (2022) · Journal of Clinical and Translational Research · doi:10.18053/jctres.08.202201.010 · Cited by 3 · see citing works
Sleep quality in head and neck cancer patients
Santoso, A. M. M. (2023) · doi:10.5463/thesis.226 · Cited by 3 · see citing works
Pennington, K. P., Schlumbrecht, M., McGregor, B. A., Goodheart, M. J., Heron, L., Zimmerman, B., Telles, R., Zia, S., Penedo, F. J., & Lutgendorf, S. K. (2024) · Contemporary Clinical Trials · doi:10.1016/j.cct.2024.107612 · Cited by 3 · see citing works
Self-citationSubih, H. S., Al-Shwaiyat, E. A., Al-Bayyari, N. S., Obeidat, B. S., Farsakh, F. A., & Bawadi, H. A. (2023) · Nutrients · doi:10.3390/nu15245087 · Cited by 2 · see citing works
Surti, M., Gupta, A., Janiyani, K., Adnan, M., & Patel, M. B. (2026) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2026.01.009 · Cited by 2 · see citing works
“245 Adding further biological insight, Cuneo et al. identified oxytocin, a hormone associated with social bonding within the ovarian TME, suggesting that positive psychosocial interactions might exert antitumor effects through neuroendocrine and immune-modulating mechanisms.”
Benoit, M., Sylvestre, M., Datta, G. D., Gilbert, L., Ho, V., Karp, I., Lacaille, J., Lau, S. K., Samouëlian, V., & Koushik, A. (2024) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2024.101540 · Cited by 2 · see citing works
“Consistent with our research, prior studies evaluating sleep quality in women diagnosed with ovarian cancer reported a prevalence of poor sleep quality of 58 – 67 % after treatment (Clevenger et al., 2013; Sandadi et al., 2011).”
InfluentialOliva, D., Jensen, L. D., Sharp, L., Nilsson, M., & Lewin, F. (2019) · Journal of Neurology and Neuroscience · doi:10.21767/2171-6625.1000284 · Cited by 2 · see citing works
Quality of life and survivorship in patients with low-grade ovarian cancer
Lemieux, M., Telles, R., Goodheart, M. J., Dahmoush, L., Hagemann, I. S., Penedo, F. J., Nandakumar, R., Cole, S. W., Sood, A. K., Lutgendorf, S. K., et al. (2024) · Gynecologic Oncology · doi:10.1016/j.ygyno.2024.08.010 · Cited by 1 · see citing works
Self-citationŞancı, M., Görgülü, G., & Can, B. (2024) · Psychogeriatrics · doi:10.1111/psyg.13149 · Cited by 1 · see citing works
Pirinççi, C. Ş., Yaşa, M. E., Özdemir, E. E., Dalyan, M., & Borman, P. (2024) · Journal of Turkish Sleep Medicine · doi:10.4274/jtsm.galenos.2024.72324 · Cited by 1 · see citing works
“31 The impact of poor sleep quality on outcomes and patient QoL demonstrates the need for new therapeutic options with few side-effects.”
- Authors
- Clevenger, L., Schrepf, A., DeGeest, K., Bender, D., Goodheart, M., Ahmed, A., Dahmoush, L., Penedo, F., Lucci, J., Thaker, P. H., Mendez, L., Sood, A. K., Slavich, G. M., & Lutgendorf, S. K.
- Affiliations
- University of Iowa (US)
- Northwestern University (US)
- University of Miami (US)
- Washington University in St. Louis (US)
- Division of Gynecologic Oncology Department of Obstetrics and Gynecology Florida International University College of Medicine Miami Beach Florida
- The University of Texas MD Anderson Cancer Center (US)
- University of California, Los Angeles (US)
- Corresponding author
- Lutgendorf, Susan K.
- ORCID
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2013-06-24
- Volume
- 119
- Issue
- 17
- Pages
- 3234-3241
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- PMC
- PMC3775963
- OpenAlex
- W1521235129
- Cited by
- 127
- References
- 47
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 14 · 2023: 8 · 2022: 11 · 2021: 10 · 2020: 14 · 2019: 9 · 2018: 8 · 2017: 12 · 2016: 8 · 2015: 8 · 2014: 7 · 2013: 2 · 2012: 1
- FWCI
- 4.47
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (R21CA088293, CA-104825, CA140933, R01CA104825, R01CA140933)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Health Sciences › Medicine › Reproductive Medicine › Ovarian cancer diagnosis and treatment
- Keywords
- sleep disorders, ovarian cancer, quality of life, depression, anxiety, psychosocial distress, sleep medication, analgesics
- MeSH terms
- Carcinoma, Ovarian Epithelial, Adult, Aged, Analgesics, Antidepressive Agents, Anxiety, Depression, Female, Humans, Hypnotics and Sedatives, Longitudinal Studies, Middle Aged, Neoplasm Staging, Neoplasms, Glandular and Epithelial, Ovarian Neoplasms, Peritoneal Neoplasms, Prospective Studies, Quality of Life, Sleep Wake Disorders, Stress, Psychological, Anti-Anxiety Agents, United States, Neoplasm Grading
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
